Miyashita Akiko Moni

Miyashita Akiko Moni is listed in filings as Director at Halozyme Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 2, 2025, including 2 public disclosures. Recent filings connect the profile to Halozyme Therapeutics, Inc. (HALO). The current snapshot covers public activity from May 2, 2025. Reported amounts are shown as $345.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.